Following the appearance of an unexplained disease in a participant, the last phase of tests of a vaccine was interrupted in the United States.
It was the pharmaceutical group Johnson & Johnson who announced the suspension of his clinical trial after one of the participants fell ill. “We have temporarily interrupted the additional dosage in all our clinical trials of an experimental vaccine against the COVVI-19, including the entire phase 3 trial, due to an unexplained disease in a participant,” published the group, quoted by the AFP agency.
Grave unwanted events are “a component expected from any clinical study, especially extensive studies,” continued Johnson & Johnson.
To carry out these tests, it was necessary to initiate 60 thousand participants on more than 200 sites in the United States, and in other countries.
With the announcements here and there on the production of an effective vaccine against the coronavirus by the end of the year, the countries are starting to prepare for the “war” to have it. Tunisia is certainly partly …
In Tunisia, the director general of the National Evaluation of Evaluation, Quality Insurance and Accreditation Chokri Hammouda, said that a committee is currently working on the preparation of a file to obtain vaccination against coronavirus from its production at the end of this year.
